ObGyn
Partner With Us
Advertisement
Conexiant chevron_right ObGyn chevron_right Tampon Test Detects Endometrial Cancer
Conference News Society of Gynecologic Oncology Annual Meeting

Tampon Test May Detect Endometrial Cancer

New research from the Mayo Clinic shows promising results for a noninvasive methylated DNA marker panel that could reduce the number of unnecessary and painful biopsies in patients with abnormal uterine bleeding.

Conexiant
article Full Article subject Summary summarize Notecard
  1. Six-marker methylated DNA panel detects endometrial cancer with high sensitivity using self-collected vaginal fluid samples.
  2. The study demonstrated 89% sensitivity for detecting endometrial cancer with 85% specificity.
  3. The clinical pilot included two cohorts, and the final 6-MDM panel achieved an area under the curve (AUC) of 0.93.
  4. The study supports further development of a vaginal fluid-based test for endometrial cancer.

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.